125 related articles for article (PubMed ID: 21519180)
1. [A case of portal hypertension after the treatment of oxaliplatin based adjuvant chemotherapy for rectal cancer].
Heo J; Shin KY; Kwon YH; Park SY; Jung MK; Cho CM; Tak WY; Kweon YO
Korean J Gastroenterol; 2011 Apr; 57(4):253-7. PubMed ID: 21519180
[TBL] [Abstract][Full Text] [Related]
2. [A case of bleeding stomal varices during the course of oxaliplatin-based chemotherapy for recurrent rectal cancer].
Kobayashi N; Fukuhara T; Mesaki K; Nakagawa K; Kobayashi K; Hanaoka T; Uchinomura S; Kato T
Gan To Kagaku Ryoho; 2014 Jul; 41(7):905-7. PubMed ID: 25131882
[TBL] [Abstract][Full Text] [Related]
3. A case of liver fibrosis with splenomegaly after oxaliplatin-based adjuvant chemotherapy for colon cancer.
Kang GH; Moon HS; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY; Lee HY; Kang DY
J Korean Med Sci; 2013 Dec; 28(12):1835-8. PubMed ID: 24339718
[TBL] [Abstract][Full Text] [Related]
4. Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury.
Slade JH; Alattar ML; Fogelman DR; Overman MJ; Agarwal A; Maru DM; Coulson RL; Charnsangavej C; Vauthey JN; Wolff RA; Kopetz S
Clin Colorectal Cancer; 2009 Oct; 8(4):225-30. PubMed ID: 19822514
[TBL] [Abstract][Full Text] [Related]
5. [A case of portal hypertension after 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy].
Ogata H; Gushima T; Maruoka S; Takasaki S; Tanaka R; Matsuura T; Aishima S; Takahashi K
Nihon Shokakibyo Gakkai Zasshi; 2013 Dec; 110(12):2119-26. PubMed ID: 24305101
[TBL] [Abstract][Full Text] [Related]
6. Development of nodular regenerative hyperplasia (NRH) with portal hypertension following the administration of oxaliplatin for the recurrence of colon cancer.
Takaya H; Kawaratani H; Nakanishi K; Takeyama S; Morioka C; Sawai M; Toyohara M; Fujimoto M; Yoshiji H; Yamao J; Fukui H
Intern Med; 2015; 54(4):383-7. PubMed ID: 25748953
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.
Overman MJ; Maru DM; Charnsangavej C; Loyer EM; Wang H; Pathak P; Eng C; Hoff PM; Vauthey JN; Wolff RA; Kopetz S
J Clin Oncol; 2010 May; 28(15):2549-55. PubMed ID: 20406923
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?
Madbouly KM; Hussein AM; Zeid A
Dis Colon Rectum; 2013 May; 56(5):577-85. PubMed ID: 23575396
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of rupture of esophagogastric varices during the course of oxaliplatin-based chemotherapy for colorectal cancer].
Shigefuku R; Takahashi H; Tsuda T; Ikeda H; Matsunaga K; Matsumoto N; Okuse C; Boku N; Itoh F; Suzuki M
Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2326-36. PubMed ID: 25482909
[TBL] [Abstract][Full Text] [Related]
10. Esophagogastric varices were diagnosed in a non-cirrhotic liver case during long-term follow-up after oxaliplatin-based chemotherapy.
Shigefuku R; Watanabe T; Mizukami T; Matsunaga K; Hattori N; Ehira T; Suzuki T; Nakano H; Sato Y; Matsuo Y; Nakahara K; Ikeda H; Matsumoto N; Tsuda T; Katayama M; Koizumi S; Okuse C; Suzuki M; Otsubo T; Nakajima TE; Yasuda H; Itoh F
Clin J Gastroenterol; 2018 Dec; 11(6):487-492. PubMed ID: 29948819
[TBL] [Abstract][Full Text] [Related]
11. [Successful management with partial splenic embolization (PSE) of splenomegaly and thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced colorectal cancer].
Hiramoto K; Kuroki M; Nakano E; Kanno N; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H
Gan To Kagaku Ryoho; 2011 May; 38(5):835-9. PubMed ID: 21566449
[TBL] [Abstract][Full Text] [Related]
12. Isolated gastric variceal bleeding related to non-cirrhotic portal hypertension following oxaliplatin-based chemotherapy: A case report.
Zhang X; Gao YY; Song DZ; Qian BX
World J Gastroenterol; 2022 Jul; 28(27):3524-3531. PubMed ID: 36158260
[TBL] [Abstract][Full Text] [Related]
13. A case of percutaneous transhepatic stomal varices embolization and partial splenic artery embolization for rectal cancer after CAPOX/BEV chemotherapy: the summary of the stomal varices related to oxaliplatin administration.
Mizukami S; Shonaka T; Tani C; Ihara K; Takeda T; Ohara M; Hasegawa K; Tanino M; Sawada K; Sumi Y
Clin J Gastroenterol; 2023 Feb; 16(1):54-62. PubMed ID: 36266604
[TBL] [Abstract][Full Text] [Related]
14. [Non-cirrhotic portal hypertension presented by acute upper gastrointestinal bleeding 7 years after oxaliplatin-chemotherapy].
Schwarz S; Suppan M; Höbling W; Grünberger A; Nömeyer R; Hubner D; Knoflach P
Z Gastroenterol; 2014 Jul; 52(7):654-6. PubMed ID: 25026007
[TBL] [Abstract][Full Text] [Related]
15. [Successful management using laparoscopic splenectomy for splenomegaly and thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced rectal cancer].
Koike N; Ohshima Y; Takeuchi T; Arita S; Shinozaki E
Gan To Kagaku Ryoho; 2013 Jun; 40(6):815-7. PubMed ID: 23863666
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin toxicity presenting as a liver nodule - case report.
Alexandrino H; Oliveira D; Cipriano MA; Ferreira L; Tralhão JG; Castro E Sousa F
BMC Cancer; 2015 Apr; 15():247. PubMed ID: 25886004
[TBL] [Abstract][Full Text] [Related]
17. Arterioportal shunt incidental to treatment with oxaliplatin that mimics recurrent gastric cancer.
Kim HB; Park SG
World J Gastroenterol; 2017 Sep; 23(33):6187-6193. PubMed ID: 28970735
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer.
Angitapalli R; Litwin AM; Kumar PR; Nasser E; Lombardo J; Mashtare T; Wilding GE; Fakih MG
Oncology; 2009; 76(5):363-8. PubMed ID: 19321964
[TBL] [Abstract][Full Text] [Related]
19. Splenomegaly during oxaliplatin-based chemotherapy for colorectal carcinoma.
Jung EJ; Ryu CG; Kim G; Kim SR; Park HS; Kim YJ; Hwang DY
Anticancer Res; 2012 Aug; 32(8):3357-62. PubMed ID: 22843915
[TBL] [Abstract][Full Text] [Related]
20. Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It.
Puente A; Fortea JI; Del Pozo C; Huelin P; Cagigal ML; Serrano M; Cabezas J; Arias Loste MT; Iruzubieta P; Cuadrado A; Llerena S; Lopez C; Fábrega E; Crespo J
Cells; 2019 Nov; 8(12):. PubMed ID: 31771307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
